- Home
- VSEC vs GRFS Comparison
VSEC vs GRFS Comparison
Compare VSEC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VSEC | GRFS |
|---|---|---|
| Founded | 1959 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.9B |
| IPO Year | 1995 | 2008 |
Fundamental Metrics
Financial Performance| Metric | VSEC | GRFS |
|---|---|---|
| Price | $162.68 | $7.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $260.44 | $10.87 |
| AVG Volume (30 Days) | ★ 436.4K | 434.4K |
| Earning Date | 11-04-2026 | 07-28-2022 |
| Dividend Yield | 0.25% | ★ 1.14% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.94 | N/A |
| Revenue | ★ $760,113,000.00 | N/A |
| Revenue This Year | $63.13 | $2.15 |
| Revenue Next Year | $21.44 | $6.22 |
| P/E Ratio | $83.54 | ★ $18.67 |
| Revenue Growth | ★ 9.88 | N/A |
| 52 Week Low | $152.34 | $6.96 |
| 52 Week High | $247.85 | $9.90 |
Technical Indicators
Market Signals| Indicator | VSEC | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 56.18 |
| Support Level | $161.15 | $7.44 |
| Resistance Level | $186.49 | $7.65 |
| Average True Range (ATR) | 8.35 | 0.14 |
| MACD | 0.46 | 0.03 |
| Stochastic Oscillator | 33.06 | 95.83 |
Price Performance
Historical ComparisonAbout VSEC VSE Corporation
VSE Corp is a diversified aftermarket products and services company serving commercial and government markets. The Company's operations include aircraft and airframe parts supply and distribution, and MRO services of aircraft components and engine accessories. The Company operates as a single reportable segment: Aviation, which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.
About GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.